Sign in

CHESTcare

@chestcare.bsky.social
21 followers 120 following 38 posts

New personalized educational web tool for trans men, transmasculine, & nonbinary people. Learn about your chest cancer risk (equivalent to breast cancer in cis women). Built by trans & gender-diverse (TGD) people FOR TGD people. www.chestcare.org

PostsRepliesMedia
Reposted by CHESTcare
Warrior Megsie @warriormegsie.bsky.social · 23/01/2025
Y'all!! I host a #podcast at my job. Kicking off 3rd season with a 2-part series w/ my friend Ash, who's transmasculine nonbinary, & shares their journey with breast/chest cancer. Part I live on all listening platforms 🎧 www.buzzsprout.com/2091691/epis... #transgender #breastcancer
022
CHESTcare @chestcare.bsky.social · 23/09/2026
Thank you for reporting on our recent research study by the #CHESTcare team. If you are interested in staying up to date as we create tools for breast cancer education in #transgender people, please consider giving us a follow! #breastcancerawareness #transhealth
000
CHESTcare @chestcare.bsky.social · 23/09/2026
@attitudemag.bsky.social reported on a recent study by the #CHESTcare team!
000
CHESTcare @chestcare.bsky.social · 23/09/2026
Thanks for reporting on this research study by the #CHESTcare team. If you want to stay up to date on our work as we build educational tools about breast cancer in #transgender folk, consider giving us a follow #breastcancerawareness #lgbtq
110
CHESTcare @chestcare.bsky.social · 23/09/2026
we plan then to do similar work for transfeminine folk. Everyone deserves resources that take their entire medical history into account. #TransHealth #LGBTQ #BreastCancerAwareness
000
CHESTcare @chestcare.bsky.social · 23/09/2026
Thanks for sharing this article about research from the #CHESTcare team! Consider giving us a follow if you want to stay up to date as we create trans-specific resources for breast cancer! Right now we are tackling a personalized educational tool for transmasculine folk (called CHESTcare).
100
CHESTcare @chestcare.bsky.social · 23/09/2026
Thank you so much for sharing this article about our research study! if you would like to stay up to date as we create educational tools on this topic, please consider giving us a follow! #chestcare #breastcancerawareness #transhealth
000
CHESTcare @chestcare.bsky.social · 23/09/2026
Thank you so much for your interest in our work and for sharing this article about our research! If you are interested in staying up to date on our development of trans-inclusive educational tools, please consider giving us a follow! #transhealth #breastcancerawareness #lgbtq #cancerresearch
000
CHESTcare @chestcare.bsky.social · 23/09/2026
Once we finalize our development of our breast cancer educational tools for transmasculine people, trans women and transfeminine folk are next! Any fun ideas for their website name? #breastcancerawareness #transhealth #lgbtq
000
CHESTcare @chestcare.bsky.social · 23/09/2026
Thanks so much for your interest in our research! If you are interested in being updated about our progress creating inclusive educational tools for breast cancer, please consider giving us a follow! #breastcancerawareness #breastcancer #trans
000
CHESTcare @chestcare.bsky.social · 23/09/2026
Thank you so much for your interest in this article related to our research -- if you want to stay up to date as we develop educational tools on this topic, consider giving us a follow.
000
CHESTcare @chestcare.bsky.social · 23/09/2026
Thank you so much for sharing our recent research! If you want to stay up to date on our progress on creating trans-specific breast cancer educational tools, please consider giving us a follow!
000
Reposted by CHESTcare
The Lancet Oncology @thelancetoncol.bsky.social · 23/09/2026
🚨Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial 📑Read here: thelancet.com/journals/lan... 📺Watch here: youtu.be/3OH_3uAj-xE?...
youtu.be
Radiotherapy after Mastectomy: 5-Year Results
YouTube video by The Lancet
012
CHESTcare @chestcare.bsky.social · 18/09/2026
Thank you for sharing this study by our @chestcare.bsky.social team! If you want to stay tuned for news on web education for patients and providers, give us a follow!
011
CHESTcare @chestcare.bsky.social · 18/09/2026
Thank you for sharing information about this study from our research team! If you want to stay tuned for news on educational tools for patients and providers, give us a follow!
000
CHESTcare @chestcare.bsky.social · 18/09/2026
if you want to stay tuned for news on educational tools for patients and providers, give us a follow!
000
CHESTcare @chestcare.bsky.social · 18/09/2026
if you want to stay tuned for news on educational tools for patients and providers, give us a follow!
000
CHESTcare @chestcare.bsky.social · 18/09/2026
if you want to stay tuned for news on educational tools for patients and providers, give us a follow! We hope to also tackle education for trans women in the future!
010
CHESTcare @chestcare.bsky.social · 18/09/2026
if you want to stay tuned for news on educational tools for patients and providers, give us a follow!
011
CHESTcare @chestcare.bsky.social · 18/09/2026
Thank you for sharing information about our recent study! If you want to stay tuned for educational tools for patients and providers, give us a follow.
000
CHESTcare @chestcare.bsky.social · 18/09/2026
Thank you for sharing this study by the @chestcare.bsky.social team!
110
CHESTcare @chestcare.bsky.social · 18/09/2026
Thank you for sharing this study by our research team!
100
CHESTcare @chestcare.bsky.social · 18/09/2026
Thank you for sharing this study by the @chestcare.bsky.social team!
100
CHESTcare @chestcare.bsky.social · 18/09/2026
Thank you for sharing this study by the @chestcare.bsky.social team!
100
CHESTcare @chestcare.bsky.social · 18/09/2026
Thank you for sharing information on this study by the CHESTcare team!
121
CHESTcare @chestcare.bsky.social · 18/09/2026
Thank you for featuring this article on a CHESTcare team study!
011
CHESTcare @chestcare.bsky.social · 18/09/2026
Grateful for this feature by @them.us on a CHESTcare study!
011
CHESTcare @chestcare.bsky.social · 18/09/2026
Genetic risk screening information is key to making informed decisions about surgery (eg, how much tissue to remove) & what types of screenings are necessary before & after surgery. Stay tuned for more from the CHESTcare team & follow for news of upcoming studies using our web tool.
000
CHESTcare @chestcare.bsky.social · 18/09/2026
A few weeks ago @them.us picked up a study by the @chestcare.bsky.social. We showed that doctors are not providing enough information about breast cancer risk to trans patients who have top surgery. One thing they did not emphasize is that guidelines suggest risk screening prior to surgery (cont)
them.us
Trans Top Surgery Patients Aren’t Getting Enough Info About Breast Cancer Screening, Study Says
Researchers found that providers sometimes defer education to each other, increasing the risk of patients falling through the cracks.
122
CHESTcare @chestcare.bsky.social · 05/08/2026
@usnews.com shared a report on a recent publication from the @chestcare.bsky.social team! Check out the news story below or hit this short link to read the full, open-access publication: bit.ly/45azCKV
usnews.com
022
CHESTcare @chestcare.bsky.social · 31/07/2026
If you would like to read the associated research article, please check it out in Breast Cancer Research and Treatment -- it is open access! doi.org/10.1007/s105... #GeneSky #OncoSky #MedSky #SciSky
doi.org
Healthcare professional perspectives on hereditary breast cancer risk assessment prior to gender-affirming mastectomy - Breast Cancer Research and Treatment
Purpose Transgender and gender diverse (TGD) individuals undergoing gender-affirming mastectomy (GAM) face unique challenges related to breast cancer risk assessment and screening. This study aimed to identify factors that influence healthcare professionals’ (HCPs) integration of cancer risk evaluation, including genetic assessment, within the context of GAM and pre-surgical planning. Methods We conducted semi-structured qualitative interviews with 20 healthcare professionals - including six primary care providers, five cancer genetic counselors, six oncologists, and three plastic surgeons - experienced in caring for TGD patients considering or undergoing GAM. Using a social constructivist framework, we applied reflexive thematic analysis to explore HCP perspectives and generate key themes. Results We conceptualized five key themes: (1) HCPs perceive no clear ownership for care integration of breast cancer risk assessment; (2) conflicting guidelines force HCPs to rely on their own judgment, resulting in inconsistent practice; (3) care pathways are driven by individual HCP champions rather than standardized protocols; (4) GAM frequently occurs at young ages prior to age of population cancer risk screening initiation, complicating risk discussions; and (5) structural failures in care delivery compromise patient safety. Conclusion Improving cancer risk assessment for TGD patients undergoing GAM demands clear institutional accountability, harmonized evidence-based guidelines, standardized care pathways, and genetic counseling embedded into multidisciplinary gender-affirming care teams. These coordinated structural efforts are critical to integrate equitable, personalized, and patient-centered cancer prevention with gender-affirming surgical care.
011
CHESTcare @chestcare.bsky.social · 31/07/2026
Some news on a second publication from the @chestcare.bsky.social team that came out this week. Check out what providers said when asked about providing breast cancer risk–related care for transgender and non-binary persons preparing for gender-affirming mastectomy. #GeneSky #SciSky #MedSky #OncoSky
medicalxpress.com
New research identifies barriers transgender individuals face related to breast cancer risk
Transgender and gender-diverse (TGD) individuals experience significant health care disparities across the oncology spectrum of care. Systemic barriers, past harmful health care experiences, the socio...
222
CHESTcare @chestcare.bsky.social · 31/07/2026
Update: I added some bolding on the home page that will hopefully make it more obvious, and also included this phrasing on the page for the tool, in case people excitedly click “get started” before reading the about section.
110
CHESTcare @chestcare.bsky.social · 31/07/2026
Note that future work is planned for a sibling site to cover breast and prostate cancer in this population.
010
CHESTcare @chestcare.bsky.social · 31/07/2026
For additional language related to this clarification, do you have suggestions that would not be othering to people who are explicitly opposed to those umbrella terms or reference to assigned sex at birth but would make clearer the need? (Cont)
210
CHESTcare @chestcare.bsky.social · 31/07/2026
Based on feedback in prior studies that assigned sex at birth and umbrella terms like “transmasculine” and “transfeminine” are othering to many people, we have avoided that specific language. The tool itself is in development . (Cont)
110
CHESTcare @chestcare.bsky.social · 31/07/2026
Hi there! The “what is chestcare” section on the homepage states that the website currently only supports people who have had or are planning gender affirming mastectomy or are taking or planning to take testosterone. (Cont)
110
CHESTcare @chestcare.bsky.social · 29/07/2026
Please check out CHESTcare team member Kai’s first first author paper in the International Journal of Transgender Health! Kai did qualitative interviews with 14 trans & nonbinary folk with increased cancer risk. We are all very proud to be part of this research effort.
tandfonline.com
Epistemic injustice in preventative cancer care for transgender individuals in the United States
Transgender and nonbinary (TGNB) people frequently pursue surgical or hormonal gender-affirming medical care (GAMC). While some guidelines acknowledge an impact of GAMC on cancer risk and managemen...
122
CHESTcare @chestcare.bsky.social · 22/10/2025
Please check out our new open access publication in JCO Precision Oncology on the some of the work that informed the CHESTcare prototype! ascopubs.org/doi/10.1200/...
A figure showing the conclusions of the paper. Part A shows a picture of the difference between top surgery and mastectomy as well as DNA and an MRI, and is titled "Comprehensive education on surgical options, breast cancer risk, and postoperative screening." Part B shows a conversation between a genetic counselor and patient and is labeled "Integration of genetic counselor-driven risk assessment, testing, and pre-operative risk counseling. Part C shows a conversation between a surgeon and patient about top surgery, is labeled "Informed patient-led decisions making on surgical technique balancing risk and aesthetics". Part D depicts and microscope and graph and is labeled "long term quantitative cancer outcomes data." Part E depicts ultrasound and MRI alongside a trans symbol and is labeled: "inclusive breast/chest screening and health spaces"
022
CHESTcare @chestcare.bsky.social · 07/05/2025
Thrilled to present our research on top surgery, genetics, and breast/chest cancer risk at the #BNGAP LGBT Health Workforce Conference in NYC! Looking forward to sharing updates with you all soon. 🏳️‍⚧️🏳️‍🌈 #GeneChat #OncoSky
Two androgynous presenting and one femme presenting persons standing near a conference banner that reads "LGBT Health Workforce Conference"
0132